Crinetics Pharmaceuticals Inc.
Clinical trials sponsored by Crinetics Pharmaceuticals Inc., explained in plain language.
-
New pill shows promise for controlling acromegaly Long-Term
Disease control OngoingThis study looks at the long-term safety and effectiveness of an oral medication called paltusotine for people with acromegaly, a condition caused by too much growth hormone. Participants are adults who have already completed a related study. The goal is to see if the drug can ke…
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could a pill replace needles for acromegaly patients?
Disease control OngoingThis study tests a new daily pill, paltusotine, for people with acromegaly whose hormone levels are already controlled by standard injections. The goal is to see if the pill can keep hormone levels stable and be a more convenient treatment option. About 58 adults will take either…
Phase: PHASE3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New pill could tame acromegaly without surgery
Disease control OngoingThis study tests a new daily pill, paltusotine, for people with acromegaly (a condition causing too much growth hormone). About 111 adults who are not currently on other treatments will receive either the pill or a placebo. The goal is to see if the pill can safely lower hormone …
Phase: PHASE3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC